Coloplast A/S (OTCMKTS:CLPBY) Sees Strong Trading Volume After Analyst Upgrade

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw strong trading volume on Thursday after Sanford C. Bernstein upgraded the stock to a hold rating. 1,386,759 shares were traded during mid-day trading, an increase of 241% from the previous session’s volume of 407,150 shares.The stock last traded at $8.60 and had previously closed at $8.48.

Coloplast A/S Stock Down 1.7%

The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 1.20. The company has a market capitalization of $19.04 billion, a P/E ratio of 35.21, a PEG ratio of 0.84 and a beta of 0.26. The firm’s 50 day moving average price is $8.73 and its two-hundred day moving average price is $9.12.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, November 4th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.02). Coloplast A/S had a return on equity of 24.99% and a net margin of 13.01%.The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. Equities research analysts forecast that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.